IBD Medications: P19/P40 Inhibitors by Dr. Sara Horst
Автор: The ASSIST IBD Study
Загружено: 2022-07-07
Просмотров: 112
In this video, Dr. Sara Horst – Associate Professor of Medicine and Gastroenterologist at Vanderbilt University School of Medicine – explains key information for IBD patients who are on P19/P40 inhibitors, including ustekinumab (Stelara) and risankizumab-rzaa (Skyrizi).
This educational video was designed for patients with IBD as part of the ASSIST study. Patients enrolled in the study have access to a remote monitoring and digital engagement system (Tappt, powered by Synchronyx) which helps patients to stay adherent to their medications and connected to their healthcare teams.
The ASSIST study is funded by the Crohn's and Colitis Foundation.
To access additional patient education and resources visit: https://www.crohnscolitisfoundation.org/
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
